Yahoo
NYSE - Delayed Quote USD

Allurion Technologies Inc. (ALUR)

0.0210 0.0000 (0.00%)
As of October 30 at 4:00:00 PM EDT. Market Open.
Chart Range Bar
Loading chart for ALUR
  • Previous Close 0.0210
  • Open 0.5500
  • Bid 0.4000 x 1154600
  • Ask 0.6572 x 100000
  • Day's Range 0.5500 - 0.5500
  • 52 Week Range 0.0100 - 8.5200
  • Volume 2
  • Avg. Volume 2,543
  • Market Cap (intraday) 12,760
  • Beta (5Y Monthly) -0.03
  • PE Ratio (TTM) --
  • EPS (TTM) -54.7500
  • Earnings Date (est.) Aug 12, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.

www.allurion.com

38

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ALUR
98.29%
S&P 500 (^GSPC)
10.80%

1-Year Return

ALUR
98.84%
S&P 500 (^GSPC)
10.69%

3-Year Return

ALUR
99.98%
S&P 500 (^GSPC)
74.03%

5-Year Return

ALUR
99.99%
S&P 500 (^GSPC)
62.74%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 2.95M
Earnings --
Profit Margin 0.00%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-10M
-5M
0
-400.0%
-300.0%
-200.0%
-100.0%
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -264.74%

  • Return on Assets (ttm)

    -66.80%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    12.6M

  • Net Income Avi to Common (ttm)

    -33.35M

  • Diluted EPS (ttm)

    -54.7500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.06M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -13.37M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: